DB-2306

N/A

Report date: 2024/04/22 14:00:45

Base Information

Drug NameDB-2306

Drug Alias NameDB-2306

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionTumor necrosis factor α inhibitorsGlucocorticoid receptor modulators

TargetsTumor necrosis factor αGlucocorticoid receptor

Therapy Area/IndicationsInflammationAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesDuality Biologics (Suzhou) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesDuality Biologics (Suzhou) Co Ltd

Inactive CompaniesN/A

Active IndicationsAutoimmune Diseases

Inactive IndicationsInflammation

Other Information

ATC CodeN/A